Stockysis — AI-Powered Stock News & Sentiment Analysis

Baird Initiates Coverage On PROCEPT BioRobotics with Neutral Rating, Announces Price Target of $30

Benzinga Newsdesk www.benzinga.com Neutral 82.6%

Neg 0% Neu 82.6% Pos 0%

Baird analyst David Rescott initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Neutral rating and announces Price Target of $30.

Comments

No comments yet. Be the first!